Preparation of cultured skin for transplantation using insulin-like growth factor I in conjunction with insulin-like growth factor binding protein 5, epidermal growth factor, and vitronectin

Transplantation

Volumn 81, Issue 12, 2006, Pages 1668-1676

  Dawson, Rebecca A ^a   Upton, Zee ^a   Malda, Jos ^a   Harkin, Damien G ^a,b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

Epidermis; IGF I; IGFBP 5; Transplant; Vitronectin

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; RECOMBINANT PROTEIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; VITRONECTIN;

AEROSOL; ARTICLE; CELL CULTURE; CELL SUSPENSION; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; EPIDERMIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; SERUM; SKIN CULTURE; SKIN INJURY; SKIN TRANSPLANTATION;

ANIMALS; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; EPIDERMAL GROWTH FACTOR; EPIDERMIS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; MICE; PHENOTYPE; SKIN TRANSPLANTATION; TISSUE CULTURE TECHNIQUES; VITRONECTIN;

EID: 33745463974     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000226060.51572.89     Document Type: Article

References (43)

1. O'Connor NE, Mulliken JB, Banks-Schlegel S, et al. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981; 317(8211): 75.
2. Green H, Kehinde O, Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 1979; 76(11): 5665.
3. Gallico GG, 3rd, O'Connor NE, Compton CC, et al. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 1984; 311(7): 448.
4. Guerra L, Capurro S, Melchi F, et al. Treatment of "stable" vitiligo by Timedsurgery and transplantation of cultured epidermal autografts. Arch Dermatol 2000; 136(11): 1380.
5. Moustafa M, Simpson C, Glover M, et al. A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers. Diabet Med 2004; 21(7): 786.
6. Boyce S, Warden G. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 2002; 183: 445.
7. Fraulin F, Bahoric A, Harrop A, et al. Autotransplantation of epithelial cells in the pig via an aerosol vehicle. J Burn Care Rehabil 1998; 19(4): 337.
8. Wood F. Clinical potential of autologous epithelial suspension. Wounds 2003; 15(1): 16.
9. Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 1963; 17: 299.
10. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6(3): 331.
11. Haddow DB, Steele DA, Short RD, et al. Plasma-polymerized surfaces for culture of human keratinocytes and transfer of cells to an in vitro wound-bed model. J Biomed Mater Res A 2003; 64(1): 80.
12. Code of Federal Regulations, Title 21 Food and Drugs, Volume 8, Chapter 1, Food and Drug Administration, Department of Health and Human Services (USA). Part 1271 Human Cells, Tissues, and Cellular and Tissue-Based Products, Vol. 21CFR1271, 2005; 715.
13. Hultman CS, Brinson GM, Siltharm S, et al. Allogeneic fibroblasts used to grow cultured epidermal autografts persist in vivo and sensitize the graft recipient for accelerated second-set rejection. J Trauma 1996; 41(1): 51.
14. Hyde C, Hollier B, Anderson A, et al. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration. J Invest Dermatol 2004; 122(5): 1198.
15. Hollier B, Harkin DG, Leavesley D, Upton Z. Responses of keratinocytes to substrate-bound vitronectin: growth factor complexes. Exp Cell Res 2005; 305(1): 221.
16. Kratz G, Lake M, Ljungstrom K, et al. Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-1 but not IGF-2-induced cell proliferation. Exp Cell Res 1992; 202(2): 381.
17. Ristow HJ. Studies on stimulation of DNA synthesis with epidermal growth factor and insulin-like growth factor-I in cultured human keratinocytes. Growth Regul 1996; 6(2): 96.
18. Barreca A, De Luca M, Del Monte P, et al. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 1992; 151(2): 262.
19. Kuhn C, Hurwitz SA, Kumar MG, et al. Activation of the insulin-like growth factor-1 receptor promotes the survival of human keratinocytes following ultraviolet B irradiation. Int J Cancer 1999; 80(3): 431.
20. Swope VB, Supp AP, Greenhalgh DG, et al. Expression of insulin-like growth factor I by cultured skin substitutes does not replace the physiologic requirement for insulin in vitro. J Invest Dermatol 2001; 116(5): 650.
21. Rheinwald JG, Green H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 1977; 265(5593): 421.
22. Batch JA, Mercuri FA, Edmondson SR, Werther GA. Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization. J Clin Endocrinol Metab 1994; 79(5): 1444.
23. Edmondson SR, Thumiger SP, Kaur P, et al. Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo. Br J Dermatol 2005; 152(2): 225.
24. Jones JI, Gockerman A, Busby WH, Jr., et al. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 1993; 121(3): 679.
25. Brown C, Stenn KS, Falk RJ, et al. Vitronectin: effects on keratinocyte motility and inhibition of collagen-induced motility. J Invest Dermatol 1991; 96(5): 724.
26. Kim JP, Zhang K, Chen JD, et al. Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor. J Biol Chem 1994; 269(43): 26926.
27. Upton Z, Webb H, Hale K, et al. Identification of vitronectin as a novel insulin-like growth factor-II binding protein. Endocrinology 1999; 140(6): 2928.
28. Nam T, Moralez A, Clemmons D. Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions. Endocrinology 2002; 143(1): 30.
29. Kricker JA, Towne CL, Firth SM, et al. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 2003; 144(7): 2807.
30. Goberdhan NJ, Edgecombe M, Freedlander E, MacNeil S. Extracellular matrix proteins induce changes in intracellular calcium and cyclic AMP signalling systems in cultured human keratinocytes. Burns 1997; 23(2): 122.
31. Lenoir-Viale M-C. Reconstruction of human skin epidermis in vitro. In: Shaw A, ed. Epithelial cell culture: A practical approach. Oxford: Oxford University Press, 1996: 179.
32. Harkin DG, Barnard Z, Gillies P, et al. Analysis of p63 and cytokeratin expression in a cultivated limbal autograft used in the treatment of limbal stem cell deficiency. Br J Ophthalmol 2004; 88(9): 1154.
33. Chakrabarty KH, Dawson RA, Harris P, et al. Development of autologous human dermal-epidermal composites based on sterilized human allodermis for clinical use. Br J Dermatol 1999; 141(5): 811.
34. Harkin DG, Dawson RA, Upton Z. Optimized delivery of skin keratinocytes via aerosolization and suspension in fibrin tissue adhesive. Wound Repair Regen 2006; 14(3): in press.
35. Boyce ST, Ham RG. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 1983; 81(1 Suppl): 33s.
36. Higham MC, Dawson R, Szabo M, et al. Development of a stable chemically defined surface for the culture of human keratinocytes under serum-free conditions for clinical use. Tissue Eng 2003; 9(5): 919.
37. Sun T, Higham M, Layton C, et al. Developments in xenobiotic-free culture of human keratinocytes for clinical use. Wound Repair Regen 2004; 12(6): 626.
38. Liu JY, Burg G. An improved organ culture for regeneration of pure autologous keratinocytes from small split-thickness skin specimens. Dermatology 2005; 210(1): 45.
39. Poumay Y, Dupont F, Marcoux S, et al. A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch Dermatol Res 2004; 296(5): 203.
40. Boyce S, Michel S, Reichert U, et al. Reconstructed skin from cultured human keratinocytes and fibroblasts on a collagen-glycosaminoglycan biopolymer substrate. Skin Pharmacol 1990; 3(2): 136.
41. Horch RE, Debus M, Wagner G, Stark GB. Cultured human keratinocytes on type I collagen membranes to reconstitute the epidermis. Tissue Eng 2000; 6(1): 53.
42. Yashiki S, Umegaki R, Kino-Oka M, Taya M. Evaluation of attachment and growth of anchorage-dependent cells on culture surfaces with type I collagen coating. J Biosci Bioeng 2001; 92(4): 385.
43. Wang R, Clark RA, Mosher DF, Ren XD. Fibronectin's central cell-binding domain supports focal adhesion formation and Rho signal transduction. J Biol Chem 2005; 280(31): 28803.